FDA and other regulators see the exact same problems pop up time and time yet again. Many of those illustrations were taken from publicly available FDA warning letters, but there's tiny doubt that EU regulators see the same challenges. They typically drop into four types.ALCOA+ relates to the principles of data integrity in regulated industries, in